Chen, Y.-L.*, Hsieh, J.-W. A., Kuo, S.-C., Kao, C.-T., Tung, C.-C., Yu, J.-H., 「Chang, T.-H.」, Ku, C., Xie, J., Zhang, D., Li, Q., and Lin, Y.-C. J.*, 2024, “Merit of integrating in situ transcriptomics and anatomical information for cell annotation and lineage construction in single-cell analyses of Populus”, Genome Biol., 25, 85. (SCIE)
Chen, Wei
Bin Zheng, Mengyi Li, Tiange Zhang, Bowen Li, Qiuya Li, Qimanguli Saiding, Wei Chen, Mingming Guo, Seyoung Koo*, Xiaoyuan Ji*, Wei Tao*, 2024, “Functional modification of gut bacteria for disease diagnosis and treatment”, Med (Cell Press), 5, 863-885. (SCIE)
Zhongshan He#, Wei Chen#*, Kuan Hu,# Yaoyao Luo, Wanqin Zeng, Xi He, Tingting Li, Jiang Ouyang, Yongjiang Li, Lin Xie, Yiding Zhang, Qin Xu, Shuping Yang, Mengran Guo, Wei Zou, Yanfei Li, Lingjing Huang, Lu Chen, Xingcai Zhang, Qimanguli Saiding, Rui Wang, Ming-Rong Zhang, Na Kong, Tian Xie, Xiangrong Song*, Wei Tao**: Co-corresponding author; #: Co-first author, equal contribution, 2024, “Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment”, Nature Nanotechnology, doi.org/10.1038/s41565-024-01687-1, online-online. (SCIE)
Yiming Zhang, Yesi Shi, Muhammad M Khan, Fan Xiao, Wei Chen, Wei Tao*, Ke Yao*, Na Kong*, 2024, “Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases”, Trends in Biotechnology, In press, In press-In press. (SCIE)
Muhammad Muzamil Khan, Yongjiang Li, Zhuoming Zhou, Abigale Ni, Qimanguli Saiding, Duotian Qin, Wei Tao*, Wei Chen*, 2024, “Macrophage-modulating nanomedicine for cancer immunotherapy”, Nanoscale, 16, 7378-7386. (SCIE)
Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong*, Gang Liu*, Wei Chen*, Wei Tao* *: Corresponding author, 2024, “Chemically Modified Platforms for Better RNA Therapeutics”, Chemical Reviews, 124, 929-1033. (SCIE)
Chuang, Trees-Juen
Wei-Min Ho, Chia-Ying Chen, Tai-Wei Chiang, and Trees-Juen Chuang*, 2024, “Correction: A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels”, ACTA NEUROPATHOLOGICA COMMUNICATIONS, 12, 119. (SCIE)
Wei-Min Ho, Chia-Ying Chen, Tai-Wei Chiang, and Trees-Juen Chuang*, 2024, “A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels”, ACTA NEUROPATHOLOGICA COMMUNICATIONS, 12, 77 (SCI impact factor: 6.2; Rank (NEUROSCIENCES): 32/310). (SCIE)
Tai-Wei Chiang, Song-En Jhong, Yu-Chen Chen, Chia-Ying Chen, Wei-Sheng Wu*, Trees-Juen Chuang*, 2024, “FL-circAS: an integrative resource and analysis for full-length sequences and alternative splicing of circular RNAs with nanopore sequencing”, NUCLEIC ACIDS RESEARCH, 52, D115-D123 (SCI impact factor: 16.6; Rank (BIOCHEMISTRY & MOLECULAR BIOLOGY): 6/313). (SCIE)